首页     联盟介绍     组织机构     联盟会员     产品展示     技术推广     进修学习     病友会     学术进展     学术会议     对外合作     联系我们    
联盟动态
 
2018全国疼痛诊疗技术新进展系列培训班 五合一通...
联合镇痛 无痛中国 ——中国疼痛诊疗康复产学研...
第一届全国骨关节疾病微创治疗技术新进展高级...
2017中国疼痛诊疗康复产学研论坛暨第十一届全国...
第七届全国超声引导可视化疼痛治疗技能演练培...
第十二届全国神经痛微创介入治疗学习班通知
2016中国疼痛诊疗康复产学研论坛暨第十届全国临...
怀来基地挂牌仪式在同济医院隆重举行
唐山工人医院与北京宣武医院结成战略联盟
首都医科大学宣武医院疼痛诊疗中心卫人中医医...
 
联盟动态
Efficacy and safety of ozonated autohemotherapy in patients
更新时间:2015-07-09 14:29  作者:小平

【标题】:Efficacy and safety of ozonated autohemotherapy in patients with hyperuricemia and gout: A phase I pilot study

【作者】:Li, L. Y.; Ni, J. X.

【来源】:Exp Ther Med, 2014, 8(5), 1423-1427

【摘要】:Gout is a common form of arthritis; however, there are currently no effective therapies available. Ozonated autohemotherapy (O3-AHT) is a controversial, but successful method of treatment for a number of diseases. The present study is the first pilot study investigating the application of O3-AHT in patients with hyperuricemia and gout. In total, 10 patients diagnosed with gout were recruited  and subjected to O3-AHT. Self-reported pain visual analog scale (VAS) scores and  creatinine clearance values were evaluated prior to (T0), during (after the fifth session of O3-AHT treatment; 1-4 weeks; T1) and following the treatment course (5-28 weeks; T2). At T1, the creatinine clearance rate of the patients significantly increased from 105.14+/-35.33 (T0) to 121.45+/-44.52 ml/min (t=2.165, P=0.062), while the pain VAS score decreased from 5.35+/-2.78 (T0) to 3.30+/-2.21 (t=2.004, P=0.076). However, at T2, the creatinine clearance rate decreased slightly to 111.15+/-36.52 ml/min, and no statistically significant difference was observed from the value at T0 (t=1.723, P=0.123). The pain VAS score further decreased to 2.30+/-2.66 (t=2.628, P=0.027). In conclusion, O3-AHT  decreased the creatinine clearance rate and the pain VAS scores of patients with  hyperuricemia and gout; thus, may be a potential effective therapeutic approach.

【关键词】:autohemotherapy; gout; hyperuricemia; ozone

联系地址:北京市西城区长椿街45号首都医科大学宣武医院疼痛科 邮政编码:100053 
电话:010-83153105  邮箱:xwpain@263.net
© 2015  北京高新疼痛诊疗产业技术创新战略联盟  版权所有   备案号: 京ICP备15038256号
您是第339460来访者


疼痛联盟 疼痛联盟